Table of Contents
In such an event, there’s the frightening risk of large amounts of radioactive iodine (or radioiodine) being released into the atmosphere which can be breathed into lungs as well as contaminate water, soil, plants and animals, according to the Centers for Disease Control and Prevention.
Although potassium iodide itself isn’t harmful and is an important chemical that’s needed by the human body, the CDC says radioactive iodide can harm the thyroid, a butterfly-shaped gland in the front of the neck that produces many of the hormones that regulate the body.
The danger is that if radiation exposure occurs, the thyroid gland can’t distinguish between regular iodine and radioiodine and will absorb both. Too much exposure can lead to thyroid cancer.
When used as directed, potassium iodide in liquid or pill form can quickly saturate the thyroid gland and prevent it from absorbing radioactive iodine.
Price gouging sets in
Large manufacturers of potassium iodide approved for sale in the United Sates have seen their inventories rapidly depleted in recent weeks, coinciding with Russia’s invasion of Ukraine.
As supplies in the market dry up, price gouging has set in.
It’s also important to know that potassium iodide pills aren’t a cure-all and don’t offer 100% protection against radioactive iodine. The CDC warns that a single dose protects the thyroid gland for just 24 hours.
The agency said taking a higher dose, or taking it more often than recommended, does not offer more protection and can cause severe illness or death.
The CDC also cautions that potassium iodide pills only protect the thyroid and work best for certain age groups.
Out of stock
Anbex, Inc., based in New York, is a leading supplier and produces 65 mg and 130 mg IOSAT potassium iodide tablets. Its website currently shows a message saying, “We are currently out of stock of IOSAT potassium iodide 130mg and 65mg tablets.”
“We hope to be back in stock in early April but we’re pushing for late March,” said Troy Jones, vice president of sales and marketing for Anbex. Jones also runs a website www.nukepills.com that sells Anbex’s potassium iodide pills.
Jones said the company saw a rush of orders beginning in mid February of up to 15 million tablets from a variety of buyers, including individuals, resellers, hospitals, municipalities and governments worldwide.
“The big run started on February 23 through February 28. We sold out of all the inventory we had,” Jones said. Although supplies are being replenished weekly, they’re selling out just as fast. “In the past five days we’ve probably sold as much as what typically would take us half a year to sell,” he added.
Historically, demand for potassium iodide spikes when there’s a real or perceived threat of nuclear fallout, Jones said.
The escalating rhetoric from Russia only helped fuel anxiety — and the purchase of potassium iodide, manufacturers said.
Anbex, which sells its tablets in a 14- day or 20-day foil-sealed pack depending on the dosage, has ramped up production, said Jones.
London-based BTG Specialty Pharmaceuticals said it’s also experiencing heightened demand for the company’s potassium iodide products across Europe and the US.
“This has coincided with the conflict in Ukraine,” said Chris Sampson, spokesperson for London-based BTG, which also has US operations. BTG makes Thyrosafe, an FDA-appoved 65 mg over-the-counter potassium iodide tablet. A box of 20 tablets is priced at $12.95 on the company’s website.
Sampson said BTG has not been entirely out of stock, “though we have temporarily stopped accepting orders through our own website and some of our partners/distributors have been out of stock.”
“Most of our product is sold to governments, public health agencies and the military who manage stockpiles,” he said. “All of those orders are being met.”
The White House could not immediately be reached for comment on this story.
— CNN’s Brenda Goodman contributed to this report